1. Home
  2. PRSO vs ALZN Comparison

PRSO vs ALZN Comparison

Compare PRSO & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peraso Inc.

PRSO

Peraso Inc.

HOLD

Current Price

$0.89

Market Cap

7.8M

Sector

Technology

ML Signal

HOLD

Logo Alzamend Neuro Inc.

ALZN

Alzamend Neuro Inc.

HOLD

Current Price

$1.63

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRSO
ALZN
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.8M
8.3M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
PRSO
ALZN
Price
$0.89
$1.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$28.00
AVG Volume (30 Days)
488.1K
93.9K
Earning Date
03-18-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,001,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$35.76
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.15
N/A
52 Week Low
$0.52
$1.58
52 Week High
$2.37
$10.35

Technical Indicators

Market Signals
Indicator
PRSO
ALZN
Relative Strength Index (RSI) 45.01 33.99
Support Level $0.83 $1.58
Resistance Level $0.89 $2.11
Average True Range (ATR) 0.06 0.17
MACD -0.00 -0.05
Stochastic Oscillator 47.78 19.91

Price Performance

Historical Comparison
PRSO
ALZN

About PRSO Peraso Inc.

Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Share on Social Networks: